financial results
Quantum-Si Q1 Revenues Rise 84 Percent
The firm booked $842,000 in Q1 revenues, up from $457,000 in Q1 2024, though President and CEO Jeff Hawkins said it is seeing the impact of tariffs and NIH cuts.
Bionano Genomics Q1 Revenues Drop 26 Percent
The firm booked $6.5 million in revenues during Q1, the first full quarter after shifting its strategy to only focus on existing core customers.
MDxHealth Q1 Revenues Leap 22 Percent
The company's tissue-based test volume grew 41 percent while liquid-based test volume rose 9 percent.
Lucid Diagnostics Q1 Revenues Fall 17 Percent
EsoGuard esophageal precancer testing volume rose 25 percent to 3,034 tests in the first quarter compared to 2,420 tests in Q1 2024.
Grail Q1 Revenues up 19 Percent Driven by Clinical Test Growth
Grail shared new results from the NHS trial of its Galleri screening test, which brought in $29.1 million in Q1, a 24 percent increase over the same quarter last year.
May 9, 2025
May 8, 2025
May 8, 2025
Pacific Biosciences Q1 Revenues Drop 4 Percent
May 7, 2025
OraSure's Q1 Core Revenues Down 2 Percent
May 7, 2025
QuidelOrtho Q1 Revenues Slide 3 Percent
May 7, 2025
May 6, 2025